Physician profile
Eric Pfeifer
NPI 1205567138
$1,560.80
in general payments reported to CMS, 2019-2025
16 companies · $550 in 2025
The $550 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $141 · 2023: $514 · 2024: $356 · 2025: $550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,392 · Honoraria: $27.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,392.36 |
| Honoraria | $27.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $213.79 | 2022-2025 | Rocklatan, Hydrus Microstent, Clareon |
| Abbvie INC. | $212.96 | 2023-2025 | |
| Tarsus Pharmaceuticals, INC. | $201.56 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $162.75 | 2024-2025 | |
| Oyster Point Pharma, INC. | $153.53 | 2022-2025 | Tyrvaya |
| Bausch & Lomb Americas INC. | $119.19 | 2023-2025 | Vyzulta, Miebo, Envista Mx60 Iol |
| Lkc Technologies, INC. | $85.74 | 2023-2025 | |
| Thea Pharma INC. | $69.83 | 2022-2024 | Iyuzeh |
| Johnson & Johnson Vision Care, INC. | $61.92 | 2022 | |
| Horizon Therapeutics Plc | $59.48 | 2023 | Tepezza |
| Coopervision INC. | $58.57 | 2023 | Myday Contact Lens |
| Rxsight INC | $44.19 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Harrow Eye, LLC | $38.30 | 2024-2025 | Vevye |
| Biotissue Holdings INC. | $31.14 | 2024 | |
| Glaukos Corporation | $24.58 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $23.27 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Pfeifer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.